scispace - formally typeset
D

David A. Cooper

Researcher at Pfizer

Publications -  965
Citations -  81765

David A. Cooper is an academic researcher from Pfizer. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Viral load. The author has an hindex of 117, co-authored 903 publications receiving 69249 citations. Previous affiliations of David A. Cooper include Boston Children's Hospital & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Managing HIV. Part 4: Primary therapy. 4.1 Antiretroviral therapies for HIV.

TL;DR: Zidovudine (AZT) is not the only drug with some effect on HIV but new agents and better-directed use of established agents can delay progression of the disease and prevent the onset of symptoms for some time.
Journal ArticleDOI

Incidence of hiv infection in a cohort of homosexually active men

TL;DR: The decrease in HIV incidence in a cohort of homosexually active men in Sydney is consistent with findings from other cohorts followed for this length of time.
Journal ArticleDOI

Hyperlactataemia in HIV‐infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial)

TL;DR: The aim of the study was to evaluate the predictive value of clinical and molecular risk factors, including peripheral blood mononuclear cell (PBMC) mitochondrial DNA and mitochondrial RNA, for the development of lactic acidosis and symptomatic hyperlactataemia.
Journal Article

HIV and malignancy

TL;DR: An Australian perspective of the recent advances in research into malignancy in HIV-infected persons is provided.